Ex-situ machine perfusion devices for liver transplants: early value assessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: 12 March 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Status:Awaiting developmentProgramme:Health technology evaluationExpected publication date: TBC